BioNTech Publishes First Sustainability Report and Receives “Prime” Rating by ISS ESG Read more about BioNTech Publishes First Sustainability Report and Receives “Prime” Rating by ISS ESG
Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine Read more about Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine
Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY® Read more about Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®
BioNTech Broadens Management Board by Appointing Jens Holstein as CFO Read more about BioNTech Broadens Management Board by Appointing Jens Holstein as CFO
Update on Stability of COMIRNATY®: Longer Storage Possible Read more about Update on Stability of COMIRNATY®: Longer Storage Possible
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents Read more about Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
BioNTech Announces First Quarter 2021 Financial Results and Corporate Update Read more about BioNTech Announces First Quarter 2021 Financial Results and Corporate Update
BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore Read more about BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore
Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine Read more about Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine
